Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$145,374,262
+$20,530,066 QoQ
Shares Held
3,032,421
-10.7% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#26
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $598,181,374 across 8 Drug Manufacturers - General names. NVO ranks #2 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,217,376 | $280,143,283 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
3,032,421 | $145,374,262 | |
| 3 | NVS |
Novartis AG
|
788,033 | $123,500,531 | |
| 4 | LLY |
ELI LILLY & Co
|
26,091 | $31,294,330 | |
| 5 | BIIB |
Biogen Inc.
|
77,744 | $16,797,368 | |
| 6 | AMRN |
Amarin Corp Plc\Uk
|
48,369 | $771,001 | |
| 7 | SCLX |
Scilex Holding Co
|
33,064 | $257,899 | |
| 8 | NSRX |
Nasus Pharma Ltd
|
12,200 | $42,700 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,374,262 | 3,032,421 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $124,844,196 | 3,397,121 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $161,985,536 | 3,183,678 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $159,921,958 | 2,881,996 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $340,737,659 | 4,936,796 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $473,677,738 | 6,821,396 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $715,083,915 | 8,312,996 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $975,101,737 | 8,189,315 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,308,265,484 | 9,165,374 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,384,931,901 | 10,786,074 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,432,713,705 | 13,849,335 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,475,908,547 | 16,229,476 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,516,506,988 | 9,370,988 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,719,076,112 | 10,802,288 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,705,864,337 | 12,604,288 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,525,222,817 | 15,308,871 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,953,331,239 | 17,529,671 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,041,539,979 | 18,383,971 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,141,089,552 | 19,116,871 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,077,720,822 | 21,640,671 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,025,648,317 | 24,181,071 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,675,162,558 | 24,846,671 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,874,855,794 | 26,841,171 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,952,457,068 | 28,121,231 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,879,919,733 | 28,709,831 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,677,185,605 | 27,860,226 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||